AstraZeneca has revised its COVID-19 vaccine data after a public dispute with U.S. regulators, insisting that the shots offer strong protection against the disease despite allegations that it was cherry-picking numbers from its latest study.
from New York Daily News https://ift.tt/39gekyN
No comments:
Post a Comment